Vineet Laboratories Share Price | Vineet Laboratories Stock Screener
VINEETLAB
Pharmaceuticals
Share Price NSE
₹36.44
▼
-1.63 (-4.28%)
Share Price BSE
₹34.00
▲
0.60 (1.80%)
As of April 28, 2026, the Vineet Laboratories share price (NSE: VINEETLAB) is ₹36.44 on NSE and ₹34.00 on BSE, down 4.28% from the previous close, with shares trading between ₹36.00 and ₹38.69, and a 52-week range of ₹29.01–₹47.87.
Analyse VINEETLAB share price data and track historical price performance.
Use the Vineet Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Vineet Laboratories Market Cap
₹64.94 Cr.
VINEETLAB P/E Ratio (TTM)
-6.34
Vineet Laboratories P/B Ratio
1.45
EPS (TTM)
₹-21.90
Dividend Yield
-
Debt to Equity
1.71
VINEETLAB 52 Week High
₹47.87
Vineet Laboratories 52 Week Low
₹29.01
Operating Margin
-10.00%
Profit Margin
-17.86%
VINEETLAB Revenue (TTM)
₹56.00
EBITDA
₹-4.00
Net Income
₹-10.00
Total Assets
₹95.00
Total Equity
₹15.00
Vineet Laboratories Share Price Chart
Screen Vineet Laboratories share price with an interactive chart. Analyse VINEETLAB price trends and volatility across different timeframes.
Vineet Laboratories Company Profile - Fundamental Screener
Screen Vineet Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for VINEETLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE505Y01010
Vineet Laboratories Balance Sheet Screener
Screen VINEETLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 95 | 117 | 116 | 133 | 109 | 0 | 0 |
| Current Assets | 67 | 88 | 88 | 103 | 86 | 0 | 0 |
| Fixed Assets | 26 | 27 | 27 | 21 | 20 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 6 | 8 | 5 | 8 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 15 | 35 | 34 | 33 | 27 | 0 | 0 |
| Share Capital | 9 | 9 | 9 | 9 | 9 | 0 | 0 |
| Reserves & Surplus | 5 | 26 | 25 | 24 | 17 | 0 | 0 |
Vineet Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Vineet Laboratories income statement and profit fundamentals.
Analyze VINEETLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vineet Laboratories share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 56 | 77 | 151 | 212 | 192 | 244 | 0 | 0 |
| Expenses | 60 | 91 | 143 | 205 | 178 | 235 | 0 | 0 |
| EBITDA | -4 | -14 | 8 | 8 | 13 | 9 | 0 | 0 |
| Operating Profit % | -10.00% | -22.00% | 5.00% | 4.00% | 7.00% | 3.00% | 0.00% | 0.00% |
| Depreciation | 3 | 3 | 3 | 2 | 2 | 2 | 0 | 0 |
| Interest | 5 | 4 | 5 | 3 | 2 | 3 | 0 | 0 |
| Profit Before Tax | -11 | -21 | 0 | 2 | 9 | 4 | 0 | 0 |
| Tax | 0 | -1 | -1 | 1 | 3 | 2 | 0 | 0 |
| Net Profit | -10 | -20 | 1 | 1 | 7 | 2 | 0 | 0 |
| EPS | -11.00 | -21.90 | 1.11 | 1.36 | 7.16 | 2.18 | -0.27 | 0.00 |
Vineet Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen VINEETLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 12 | -7 | -10 | 8 | 28 | 0 |
| Investing Activities | -3 | -2 | -7 | -4 | -8 | 0 |
| Financing Activities | -8 | 8 | 0 | 12 | 19 | 0 |
| Net Cash Flow | 0 | 0 | -16 | 16 | 38 | 0 |
Vineet Laboratories Shareholding Pattern Screener
See Vineet Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Vineet Laboratories promoter holding and ownership changes for VINEETLAB on TickJournal.
| Item | 2026-Mar | 2026-Feb | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 5.98% | 5.98% | 12.46% | 15.89% | 29.26% | 35.85% | 35.85% | 36.07% |
| FII Holding | 0.36% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 88.74% | 89.17% | 82.41% | 78.16% | 66.95% | 58.67% | 59.33% | 60.65% |
| Other Holding | 4.92% | 4.84% | 5.12% | 5.94% | 3.79% | 5.49% | 4.83% | 3.27% |
| Shareholder Count | 9,929 | 10,042 | 10,003 | 9,682 | 9,988 | 10,025 | 10,058 | 10,300 |
Vineet Laboratories Share Dividend Screener - Share Yield Analysis
Check Vineet Laboratories dividend history with payout and yield data.
View Vineet Laboratories dividend details including ex-dates and amounts for VINEETLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.00 | 2.86% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Vineet Laboratories Stock Index Membership
See which indices include Vineet Laboratories stock.
Check VINEETLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vineet Laboratories Market Events Screener - Corporate Actions
Get Vineet Laboratories corporate actions including splits, bonuses, and buybacks.
Check Vineet Laboratories stock events that may affect VINEETLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | 14.41% | ||
| Annual General Meeting | NA | -0.32% | ||
| Annual General Meeting | NA | -3.46% | ||
| Annual General Meeting | NA | 9.41% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -2.77% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | -1.49% |
| 2026-02-07 | 2026-02-07 | Extraordinary General Meeting | NA | -14.69% |
| 2025-12-23 | 2025-12-23 | Rights | 13:12 | 0.08% |
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -2.18% |
| 2025-10-23 | 2025-10-23 | Quarterly Result Announcement | NA | 2.47% |
| 2025-07-22 | 2025-07-22 | Quarterly Result Announcement | NA | 14.09% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -13.60% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.81% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 2.63% |
Vineet Laboratories Competitors Screener - Peer Comparison
Screen VINEETLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 446,876 | 39.04 | 58,220 | 6.38% | 11,565 | 60.32 |
| Divis Laboratories | 174,652 | 67.84 | 10,560 | 8.73% | 2,520 | 44.73 |
| Torrent Pharmaceuticals | 156,365 | 73.76 | 13,886 | 20.34% | 2,138 | 62.27 |
| Cipla | 118,382 | 30.41 | 29,045 | 2.24% | 3,870 | 69.96 |
| Dr Reddys Laboratories | 113,273 | 27.63 | 33,593 | -0.44% | 3,998 | 66.21 |
| Zydus Life Science | 111,954 | 22.03 | 26,720 | 13.65% | 5,242 | 62.64 |
| Lupin | 110,605 | 20.55 | 27,488 | 19.98% | 5,345 | 68.05 |
| Mankind Pharma | 105,132 | 52.96 | 14,278 | 12.03% | 1,750 | 64.79 |
| Aurobindo Pharma | 90,835 | 25.68 | 33,385 | 3.21% | 3,376 | 69.05 |
| Laurus Labs | 81,918 | 91.20 | 6,868 | 22.01% | 890 | 72.35 |
Vineet Laboratories Company Announcements - News Screener
Screen VINEETLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-30 | Outcome Of Board Meeting Held On May 30 2026 - Deferment Of Consideration Of Audited Standalone Financial Results | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-05-26 | Board Meeting Intimation for To Consider And Approve The Audited Standalone Financial Results Of The Company For The Fourth Quarter And The Financial Year Ended March 31St 2026. | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-04-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Unaudited Standalone Financial Results Along With The Limited Review Report For The Period Ended On December 31 2025 | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday February 14 2026 As Required Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-11 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-10 | Board Meeting Intimation for Considering And Approving The Unaudited Standalone Financial Results Of The Company For The Third Quarter Ended On December 31 2025 Along With The Limited Review Report | - |
| 2026-02-07 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-02-07 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-02-04 | Announcement Under Regulation 30 (LODR) - Trading Approval Received From BSE Limited And National Stock Exchange | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-01-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-13 | Announcement under Regulation 30 (LODR)-Meeting Updates | - |
| 2026-01-12 | Intimation Of Extra-Ordinary General Meeting Of The Company And Cut-Off Date | - |